Reduction of organ of interest dose in proton therapy for oesophageal cancer through optimized setup robustness settings and online adaptation

Reducing setup robustness settings to 5 mm was feasible for most patients and reduced OOI dose. Large anatomical changes required plan adaptation. OAPT allowed further OOI dose reductions while preserving acceptable target coverage.